Mast cell degranulation in rat mesenteric venule: Effects of L-name, methylene blue and ketotifen

Pharmacological Research

Volumn 39, Issue 5, 1999, Pages 397-402

  Kimura, Masaaki ^a,b   Mitani, Hironobu ^a,b   Bandoh, Tsutomu ^a,b   Totsuka, Tetsuya ^a,b   Hayashi, Shigehiro ^a,c  

^a Tsukuba Research Institute   (Japan)

^b NOVARTIS PHARMA K K   (Japan)

^c Preclinical Development Department   (Japan)

Author keywords

Ketotifen; Mast cell; Methylene blue; Microcirculation; Nitric oxide

Indexed keywords

ARGININE METHYL ESTER; GUANYLATE CYCLASE; KETOTIFEN; METHYLENE BLUE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL DIAMETER; EXTRAVASATION; LEUKOCYTE; MALE; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; RAT; VENULE;

EID: 0033136361     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1999.0451     Document Type: Article

References (20)

1. Gaboury JP, Niu X-F, Kubes P. Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 1996; 93: 318-26.
2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiological pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
3. Moncada S, Rees DD, Schulz R, Palmer RM. Development and mechanism of a specific supersensitivity to nitrovasodilators following inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci 1991; 88: 2166-70.
4. Kubes P, Kanwar S, Niu X-F, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via Superoxide and mast cells. FASEB J 1993; 7: 1293-9.
5. Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: G222-9.
6. Ignarro LJ. Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65: 1-21.
7. Masini E, Salvemini D, Pistelli A, Mannaioni PF, Vane JR. Rat mast cells synthesise a nitric oxide like-factor which modulates the release of histamine. Agents Actions 1991; 33: 61-3.
8. Martin U, Romer D. The pharmacological properties of a new orally active anti-anaphylactic compounds: Ketotifen, a benzocycloheptathiophene. Arzneim-ForSch Drug Res 1978; 28: 770-82.
9. Granger DN, Benoit JN, Suzuki M, Grisham MB. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989; 257: G704-8.
10. Davis MJ. Determination of volumetric flow in capillary tubes using an optical doppler velocimeter. Microvasc Res 1987; 34: 223-30.
11. House SD, Lipowsky HH. Leukocyte-endothelium adhesion: Microhemodynamics in mesentery of the cat. Microvasc Res 1987; 34: 363-79.
12. G-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol 1990; 101: 625-31.
13. Martin GR, Bolofo ML, Giles H. Inhibition of endothelium-dependent vasorelaxation by arginine analogues: A pharmacological analysis of agonist and tissue depndence. Br J Pharmacol 1992; 105: 643-52.
14. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708-16.
15. Masini E, Di Bello MG, Pistelli A, Raspanti S, Gambassi F, Mugnai L, Lupini M, Mannaioni PF. Generation of nitric oxide from nitrovasodilators modulates the release of histamine from mast cells. J Physiol Pharmacol 1994; 45: 41-53.
16. Hogaboam CM, Befus AD, Wallace JL. Modulation of rat mast cell reactivity by IL-1β-divergent effects on nitric oxide and platelet-activating factor release. J Immunol 1993; 151: 3767-74.
17. Niu X-F, Ibbotson G, Kubes P. A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ Res 1996; 79: 992-9.
18. Salvemini D, Masini E, Anggard E, Mannaioni PF, Vane JR. Nitric oxide: A regulatory mediator of mast cell reactivity. Biochem Biophys Res Commun 1990; 169: 596-601.
19. Heyman SN, Karmeli F, Brezis M, Rachmilewitz D. The effect of ketotifen on nitric oxide synthese activity. Br J Pharmacol 1997; 120: 1545-51.
20. Kamei C, Akagi M, Mio M, Kitazumi K, Izushi K, Masaki S, Tasaka K. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitiveity reactions: (I) elucidation of the mechanism for histamine release inhibition. Immunopharmacol Immunotoxicol 1992; 14: 191-205.